DE3673129D1 - Alkylcarbonsaeureamide von pyridinalkylaminen, ihre herstellung und ihre verwendung als arzneimittel. - Google Patents

Alkylcarbonsaeureamide von pyridinalkylaminen, ihre herstellung und ihre verwendung als arzneimittel.

Info

Publication number
DE3673129D1
DE3673129D1 DE8686402210T DE3673129T DE3673129D1 DE 3673129 D1 DE3673129 D1 DE 3673129D1 DE 8686402210 T DE8686402210 T DE 8686402210T DE 3673129 T DE3673129 T DE 3673129T DE 3673129 D1 DE3673129 D1 DE 3673129D1
Authority
DE
Germany
Prior art keywords
alkylamines
pyridine
production
acid amides
medicinal products
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8686402210T
Other languages
English (en)
Inventor
Claude Laruelle
Marcel Lepant
Bernard Raynier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Panmedica SA
Original Assignee
Panmedica SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Panmedica SA filed Critical Panmedica SA
Application granted granted Critical
Publication of DE3673129D1 publication Critical patent/DE3673129D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/40—Acylated substituent nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/89—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE8686402210T 1985-10-11 1986-10-06 Alkylcarbonsaeureamide von pyridinalkylaminen, ihre herstellung und ihre verwendung als arzneimittel. Expired - Fee Related DE3673129D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MA20776A MA20552A1 (fr) 1985-10-11 1985-10-11 Alkylacarboxamides de pyridylalkylamines,leurs preparations et leurs utilisations

Publications (1)

Publication Number Publication Date
DE3673129D1 true DE3673129D1 (de) 1990-09-06

Family

ID=32292295

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8686402210T Expired - Fee Related DE3673129D1 (de) 1985-10-11 1986-10-06 Alkylcarbonsaeureamide von pyridinalkylaminen, ihre herstellung und ihre verwendung als arzneimittel.

Country Status (13)

Country Link
US (1) US4794121A (de)
EP (1) EP0223647B1 (de)
JP (1) JPS63270663A (de)
KR (1) KR870003987A (de)
AT (1) ATE55123T1 (de)
AU (1) AU600676B2 (de)
CA (1) CA1282413C (de)
DE (1) DE3673129D1 (de)
ES (1) ES2016931B3 (de)
FR (1) FR2591591B1 (de)
GR (1) GR3000969T3 (de)
MA (1) MA20552A1 (de)
ZA (1) ZA867397B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4797411A (en) * 1986-07-18 1989-01-10 Farmitalia Carlo Erba S.P.A. Cycloalkyl-substituted 4-pyridyl derivatives and use as aromatase inhibitors
US4716175A (en) * 1987-02-24 1987-12-29 Warner-Lambert Company Saturated fatty acid amides as inhibitors of acyl-CoA:cholesterol acyltransferase
ATE166051T1 (de) * 1987-08-01 1998-05-15 Takeda Chemical Industries Ltd Zwischenprodukte, ihre herstellung und verwendung zur herstellung alpha-ungesättigter amine
US7276555B2 (en) * 2002-05-21 2007-10-02 Hexion Specialty Chemicals, Inc. Amide-modified resin or hydrocarbyl moiety for dispersing a pigment

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES420074A1 (es) * 1973-10-30 1976-07-01 Made Labor Sa Un metodo para la produccion industrial de dipropilacetami-das n-sustituidas.
ES479959A1 (es) * 1979-04-26 1979-12-01 Made Labor Sa Un procedimiento para la produccion industrial de 1,2-diaci-lamino-1,2-di(4-piridil)etanos.
US4452983A (en) * 1981-06-08 1984-06-05 Riker Laboratories, Inc. Phenolic derivative
IL69392A (en) * 1982-08-13 1987-01-30 Sanofi Sa N-oxide nicotinamide derivatives,their preparation and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
ATE55123T1 (de) 1990-08-15
CA1282413C (en) 1991-04-02
GR3000969T3 (en) 1991-12-10
FR2591591A1 (fr) 1987-06-19
EP0223647B1 (de) 1990-08-01
JPS63270663A (ja) 1988-11-08
AU6306886A (en) 1987-04-16
EP0223647A3 (en) 1987-09-30
MA20552A1 (fr) 1986-07-01
EP0223647A2 (de) 1987-05-27
ES2016931B3 (es) 1990-12-16
ZA867397B (en) 1987-05-27
AU600676B2 (en) 1990-08-23
FR2591591B1 (fr) 1988-11-18
KR870003987A (ko) 1987-05-06
US4794121A (en) 1988-12-27

Similar Documents

Publication Publication Date Title
HU892555D0 (en) Process for producing complex compounds of platinum (ii) and pharmaceutical preparatives containing such compounds as active substance
PT85014A (fr) Derives de benzo ]b" thiophene et benzo ]b" furannecarboxamides leurs procedes de preparation et les medicaments les contenant
FR2361901A1 (fr) Derives de substitution de nucleotides et medicament contenant ces substances
NO933200L (no) Substituerte cykloheksanderivater, fremgangsmåte til fremstilling derav og anvendelsen av forbindelsene til behandling av sykdommer
DE3579004D1 (de) Neue sulfobetaine von ammoniocarbonsaeureamiden und verfahren zu ihrer herstellung.
ES2039267T3 (es) Dihidropiridinamidas, procedimiento para su preparacion y su empleo en medicamentos.
FR2660657B1 (fr) Nouveaux derives du 3-aminochromane, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
DE3673129D1 (de) Alkylcarbonsaeureamide von pyridinalkylaminen, ihre herstellung und ihre verwendung als arzneimittel.
ATE121405T1 (de) Oxazolopyridinderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen.
ATE21101T1 (de) N-iminopyridinium-betain-derivate, ihre herstellung und ihre verwendung als arzneimittel.
ATE70182T1 (de) Therapeutische mittel zur behandlung von magengeschwueren.
ATE44961T1 (de) Substituierte o-sulfonyl-glycosylamide, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel.
ATE177424T1 (de) N-substituierte naphthalimide, ihre herstellung und verwendung
DE3780191D1 (de) Octahydroindolizine analgesica und 7-keto-zwischenprodukte.
DK7286D0 (da) Octahydroindoliziner
SE8601733L (sv) 1-hydroxi-8-acyloxi-10-acyl-antroner, sett att framstella dessa och deras anvendning human- och veterinermedicin och i kosmetika
ES8504137A1 (es) Procedimiento para la obtencion de derivados de diaril-imidazol.(como desglose y con prioridad de la patente espanola n 504.787, presentada el 17 de agosto de 1981)
ATE82747T1 (de) Verfahren zur herstellung von hydroxyalkylierungsmitteln, die erhaltenen mittel und deren verwendung.
ATE162195T1 (de) 4-hydroxy-phenyl-beta-d-glukose-monoester, verfahren zur ihrer herstellung und ihre verwendung in der kosmetik, der pharmazie, als zahnpflegemitteln und lebensmitteln
DE3862083D1 (de) Salze von 6-piperidino-2,4-diaminopyrimidin-3-oxyd und von derivaten der thiamorpholin-3-on-5-carbonsaeure und deren verwendung in kosmetischen stoffen und als heilmittel.
ATE70050T1 (de) 1-benzoyl-2-oxo-5-alkoxy-pyrrolidin-derivate, ihre herstellung und verwendung als heilmittel und zubereitungen, die sie enthalten.
ES2043778T3 (es) Procedimiento para preparar oxiindanos y tetrahidronaftalenos herbicidas.
SE7903233L (sv) Bensylidenestrar
SE8200745L (sv) Nya derivat av 1,8-dihydroxi-9-antron-serien, substituerade i 10-stellningen med en omettad grupp och anvendning derav inom human- eller veterinermedicinen och inom kosmetiken
DE59105961D1 (de) 2,13-disubstituierte ergoline, deren herstellung und verwendung in arzneimitteln.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee